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An implantation of a cardioverter-deﬁbrillator was attempted in a 32-year-old man with
atrial tachycardia, ventricular tachycardia and sinus node dysfunction. He had undergone a
Senning operation and half closure of ventricular septal defect in order to correct a
transposition of the great arteries. Cardiac catheterization revealed severe pulmonary
hypertension and Eisenmenger syndrome. Prior knowledge of the complex cardiac anatomy
obtained by magnetic resonance imaging helped in determining the suitable site for
implanting the leads and planning the procedural strategy. With repletion of a large amount of
saline and oral anticoagulation with warfarin, no complications related to thromboembolism
occurred during a 10-month follow-up period.
(J Arrhythmia 2009; 25: 107–111)
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Introduction
Arrhythmias are common and generally poorly
tolerated in patients with Eisenmenger syndrome and
congenital heart disease.1–3) However, implantation
of an implantable cardioverter-deﬁbrillator (ICD) is
technically challenging because of the complex
anatomy, atrial scar, and presence of artiﬁcial tissue.
We describe here a case of atrial tachycardia (AT),
ventricular tachycardia (VT) and Eisenmenger syn-
drome after a Senning’s operation for a transposition
of the great arteries (TGA) (type II) in which an ICD
was successfully implanted under the guidance of
magnetic resonance imaging (MRI).
Case Report
A 32-year-old Japanese man was transferred to
our hospital for treatment of AT and VT. At the age
of 3, he was diagnosed with TGA and underwent
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Case Report
pulmonary artery banding because his pulmonary
artery pressure was elevated due to an increased
pulmonary blood ﬂow through a large ventricular
septal defect (VSD). Six years later, he underwent an
atrial switch operation with a Senning operation and
half closure of the VSD because the pulmonary
vascular resistance had signiﬁcantly increased to
2024 dyne
s
cm5 on the cardiac catheterization.
On February 1, 2008, he had a sudden palpitation
attack, and was admitted to a hospital. The diagnosis
of AT with 2:1 A-V conduction was made, and
a 12-lead ECG revealed a sustained wide QRS
tachycardia with a right bundle branch block
conﬁguration, north-west axis, and heart rate of
134 bpm (Figure 1A). Intravenous treatment with
verapamil and adenosine triphosphate could not
terminate the AT (Figure 1B), and the AT was
ﬁnally terminated by direct current cardioversion
(Figure 1C). Two days after the ﬁrst AT episode, the
patient developed a sustained monomorphic VT with
a right bundle branch block conﬁguration, left axis
deviation, and cycle length of 280msec (Figure 2),
and was also terminated by direct current cardiover-
sion. Treatment with 200mg/day of oral amiodarone
failed to control both tachycardias, but it resulted in
sinus bradycardia.
He was referred to our hospital for further
evaluation and treatment of the tachycardias. Despite
a reduction in the amount of amiodarone to 100
mg/day, successive 12-lead ECGs after admission
demonstrated a sinus bradycardia or junctional
escape rhythm with a heart rate of 40 to 45 bpm.
Echocardiography disclosed that the left ventricular
wall motion was mildly impaired with an ejection
fraction of 50%. Right heart catheterization revealed
severe pulmonary arterial hypertension with a
pulmonary arterial pressure of 105/50mmHg (mean,
77mmHg). The anatomical left ventricular and
anatomical left atria pressures were 110/13mmHg
and 6/8 (6) mmHg, respectively. A left heart
catheterization demonstrated an aortic pressure of
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Figure 1 Twelve-lead ECGs.
A. Atrial tachycardia with 2:1
atrioventricular conduction. B.
Small but distinct P waves (the
P-P interval was approximately
220ms) were observed after the
application of 20mg of adeno-
sine triphosphate. C. Sinus
rhythm after external cardiover-
sion.
J Arrhythmia Vol 25 No 2 2009
108
L/min/m2, and the left-to-right and right-to-left
(venous blood from the anatomical left ventricle to
the right ventricle) shunt ratios were 0.67 and 0.18,
respectively. Measurement of the arterial blood
gases revealed a pH of 7.528, CO2 tension of
28.8mmHg, O2 tension of 54.9mmHg and O2
saturation of 91.7%. Based on those results, the
patient was diagnosed with Eisenmenger syndrome.
Treatment with oral angiotensin converting enzyme
inhibitors and bosentan was started and total doses
were gradually increased.
We decided to implant an ICD device with a dual-
chamber (DDD) pacing function, transvenously
under local anesthesia to resolve the symptoms from
his tachycardias and sinus nodal dysfunction. Con-
sidering the complex anatomy and the risk of
thromboembolic complications, an electrophysiolog-
ical study and catheter ablation were avoided in this
case. Fortunately the AT and VT were completely
suppressed with oral medications at that time. Before
the operation, cardiac MRI was performed to
determine the exact complex anatomy and the
appropriate site for implanting the atrial pacing lead.
The MRI images disclosed that the superior vena
cava (SVC) was connected to the morphological left
atrium (LA; Figure 3A), and that the roof area of the
LA seemed to be the most appropriate site for the
implantation of the atrial pacing lead because of the
presence of an almost completely intact myocardium
and the absence of any complicated structures
around that area (Figure 3A). The morphology and
appearance of the morphological left ventricle was
also clearly seen in those images.
The patient underwent an implantation of a dual-
chamber ICD (Virtuoso DR D164AWG, Medtronic,
Minneapolis, MN, USA). Using a left-sided ap-
proach, a subclavian venous access was utilized.
Angiography of the SVC was performed in multiple
directions with special attention being paid to the














Figure 2 Twelve-lead ECG of
a monomorphic sustained ven-
tricular tachycardia.
P waves, independent of the QRS
complex, were observed in lead II
(arrows).
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angiographic images and ﬂuoroscopy, an active-
ﬁxation atrial lead was inserted into the LA, and the
atrial lead (Tendril 1488T 52 cm, St. Jude Medical,
St. Paul, MN, USA) was implanted at the exact site
of the LA roof that we found to be an appropriate site
for the implantation via the MRI (Figure 3A). The
ICD lead (Riata ST OPTIM 7020, St. Jude Medical)
was also placed in the morphological left ventricle
with no diﬃculty (Figure 3B). The stability of both
leads was excellent. The atrial pacing threshold
was 0.9V at a pulse width of 0.4ms and the
ventricular pacing threshold was also good at
0.5V at a pulse width of 0.4ms. The P wave and
R wave sensing was good at 3mV and 14mV,
respectively. There was no diaphragmatic stimula-
tion either with atrial or ventricular pacing at high
output. No far-ﬁeld sensing was observed after
connection to the device. Rapid ventricular ﬁbrilla-
tion was induced by a T-wave shock and the events
were successfully deﬁbrillated with an energy of
<20 J. The device was programmed as follows:
(i) VT detection ¼ 133{140 bpm for monitoring
purposes only; (ii) VT detection ¼ 141{187 bpm,
therapies ¼ anti-tachycardia pacing 2, 20J 1,
35J 3 and (iii) VF detection ¼ 188 bpm,
therapies ¼ 35J 6. The total procedure time was
180 minutes, and there were no procedural compli-
cations. To avoid dehydration and any thromboem-
bolic complications from the ventricular endocardial
lead placement, a large amount (200mL/h) of
intravenous saline was administered during the
operation. Warfarin was administered from the next
day after the operation in order to keep the PT-INR
(prothrombin time-internationalized ratio) at or
above 2.5. A dose of 100mg/day of aspirin was
also given to the patient. The patient has done well
with no recurrence of any tachycardia or potential
complications including a thromboembolism during
a 10-month follow-up period.
Discussion
To the best of our knowledge, this case report
demonstrated for the ﬁrst time that an ICD implan-
tation was possible with no potential complications
in a patient with Eisenmenger syndrome after a
Senning’s operation for a TGA, and that prior
knowledge of the complex cardiac anatomy obtained
with the MRI helped in determining the suitable site
for the insertion of the pacemaker lead and in
planning the procedural strategy.
Before the 1980s, most patients with TGA were
treated by an atrial inﬂow correction using a Mustard







Figure 3 A. Images of
balanced turbo-ﬁeld echo
cardiac magnetic resonance
imaging (MRI) before the
operation.
Coronal (left) and sagittal
(right) cardiac MRI images
demonstrate a superior vena
cava to left atrium (LA) con-
duit (arrow). The arrowheads
indicate the site where we
planned to implant an atrial
pacing lead in the LA roof.
B. Posterioranterior (left)
and lateral (right) views of
the chest X-ray ﬁlm after the
operation.
Note that the atrial lead (ar-
row) was implanted at the site
which we determined it should
be implanted using cardiac
MRI guidance prior to the
operation.
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been improving, arrhythmias and late deaths are
well-recognized complications.4,5) Sudden death has
been the common cause of late deaths and AT and
VT have been identiﬁed as predictors of sudden
death.4,5) Sinus node dysfunction is also common in
adult patients with a TGA, and sinus rhythm has
been reported to be preserved in only 40% of the
patients at 20 years of age.6) An Eisenmenger
physiology is a serious complication of an atrial
switch repair for a TGA and occurs in approximately
7% of those who survive to adulthood.6) Symptoms
of tachycardia or a previously documented supra-
ventricular tachycardia are the best predictors of
sudden cardiac death,1) and aggressive therapy with
antiarrhythmic medications, pacing, or even an ICD
implantation may be recommended. However, a
recent study reported that neither drug therapy nor
pacemakers reduce the risk of sudden death in
patients with a TGA who have undergone an atrial
inﬂow correction operation.5) In our case, AT, VT
and sinus node dysfunction were documented, and
an Eisenmenger physiology was also present. Sur-
gery and general anesthesia are well-known critical
factors associated with the deterioration and death
related to Eisenmenger syndrome.2) Therefore, we
think that the transvenous implantation of an ICD
device with DDD pacing was indispensable for
preventing any sudden death in this case.
The risk of thromboembolic complications from
the ventricular endocardial lead placement was a
major concern in our patient. A paradoxical embo-
lism due to the ventricular endocardial lead place-
ment might be a potential source for a throm-
boembolism, which might result in neurological
complications. With repletion using a large amount
of saline and oral anticoagulation with warfarin, no
complications related to thromboembolisms occur-
red during the operation and the follow-up period in
this case.
The device implantation in this case was techni-
cally challenging because of the unusual orientation
of the cardiac chambers. The MRI can be used to
determine the exact intracardiac anatomy and con-
ﬁrm the location and size of the intracardiac or
extracardiac communications, especially in patients
with a complex cardiac anatomy and inadequate
echocardiographic windows.7) Compared to ECG-
gated computed tomography, this imaging exposes
the patient to no ionizing radiation.8) Furthermore, it
can also provide information on the cardiac function
and characteristics of the myocardium. In our case,
prior knowledge of the cardiac anatomy from the
MRI was very helpful in determining the site for the
implantation of the atrial lead and in planning the
procedural strategy. Therefore, we think that cardiac
MRI is a very useful non-invasive method for use
prior to the device implantation in patients with a
complex cardiac anatomy as in this case, and a
detailed assessment of the MRI images before the
operation could result in a smooth, safe and
successful device implantation without any compli-
cations in these patients.
References
1) Sreeram N: Eisenmenger syndrome: towards identifying
the risk factors for death. Eur Heart J 2006; 27: 1644–
1645
2) Daliento L, Somerville J, Presbitero P, et al: Eisenmeng-
er syndrome. Factors relating to deterioration and death.
Eur Heart J 1998; 19: 1845–1855
3) Dore A, Santagata P, Dubuc M, et al: Implantable
cardioverter deﬁbrillators in adults with congenital heart
disease: a single center experience. Pacing Clin Electro-
physiol. 2004; 27: 47–51
4) Flinn CJ, Wolﬀ GS, Dick M 2nd et al: Cardiac rhythm
after the Mustard operation for complete transposition of
the great arteries. N Engl J Med 1984; 310: 1635–1638
5) Kammeraad JA, van Deurzen CH, Sreeram N et al:
Predictors of sudden cardiac death after Mustard or
Senning repair for transposition of the great arteries. J
Am Coll Cardiol 2004; 44: 1095–1102
6) Warnes CA: Transposition of the great arteries. Circu-
lation 2006; 114: 2699–2709
7) de Roos A, Roest AA: Evaluation of congenital heart
disease by magnetic resonance imaging. Eur Radiol
2000; 10: 2–6
8) Bailliard F, Hughes ML, Taylor AM: Introduction to
cardiac imaging in infants and children: techniques,
potential, and role in the imaging work-up of various
cardiac malformations and other pediatric heart condi-
tions. Eur J Radiol 2008; 68: 191–198
Arimoto T Implantable cardioverter deﬁbrillator in Eisenmenger syndrome
111
